Medicure Inc.
MCUJF
$0.80
-$0.04-4.24%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 49.55% | 45.51% | 56.79% | 27.70% | -9.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.55% | 45.51% | 56.79% | 27.70% | -9.53% |
| Cost of Revenue | 72.95% | 169.27% | 126.58% | 44.52% | 19.39% |
| Gross Profit | 27.82% | -27.10% | -1.90% | 15.08% | -26.14% |
| SG&A Expenses | 6.90% | 82.17% | 5.45% | 4.80% | -13.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.77% | 109.99% | 48.60% | 15.98% | -2.86% |
| Operating Income | 42.18% | -1,792.38% | -12.12% | 38.16% | -153.27% |
| Income Before Tax | 37.54% | -867.54% | -295.55% | 34.96% | -851.81% |
| Income Tax Expenses | -75.47% | -59.04% | 1,335.14% | -47.89% | 15.22% |
| Earnings from Continuing Operations | 39.62% | -666.51% | -303.29% | 36.13% | -1,379.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.62% | -666.51% | -303.29% | 36.13% | -1,379.37% |
| EBIT | 42.18% | -1,792.38% | -12.12% | 38.16% | -153.27% |
| EBITDA | 2,282.14% | -2,121.77% | -25.73% | 70.64% | -102.51% |
| EPS Basic | 39.52% | -665.44% | -303.14% | 36.15% | -1,386.11% |
| Normalized Basic EPS | 37.59% | -2,557.35% | -11.54% | 34.92% | -211.36% |
| EPS Diluted | 40.98% | -665.44% | -303.14% | 34.09% | -1,455.56% |
| Normalized Diluted EPS | 37.13% | -2,557.35% | -11.54% | 34.92% | -209.09% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -0.57% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |